Health TrialsbyHealthPanel

Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen?

ConditionOmega-3 Fatty Acids
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFatty Acid Research Institute

About this trial

The goal of this project is to evaluate the efficacy of personalized dosage recommendations of Parasol Omega-3 Fish Oil on achieving an Omega-3 Index of \>8% in individuals with a baseline Omega-3 Index \<8% over a 90-day period.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Baseline omega-3 index less than 8%

Disqualifiers

Currently taking a fish oil or other omega-3 supplement

Trial design

Design model

Single group

Treatments tested in this trial

  • Fish Oil Supplementation

    Dietary supplement

    Enrolled participants will be instructed to start taking 2 capsules per day on the day they take their baseline O3I and once O3I results are available to adjust to a personalized dose of Fish Oil, based on their baseline Omega-3 Index, and instructed to continue their current omega-3 dietary intake. Recommendations will be: * O3I \> 6.8% but ≤ 8% - 1 capsule * O3I \> 5.5% but ≤ 6.8% - 2 capsules * O3I \> 4.4% but ≤ 5.5% - 3 capsules * O3I ≤ 4.4% - 4 capsules

Treatment groups

48 Participants
are divided into 1 treatment group
Group A: Fish oil supplementation armExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Omega-3 index

RBC omega-3 index value

Time frame
90 days

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fatty Acid Research Institute

Lead sponsor

Omegaquant Analytics, LLC

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: